It’s a great time to start a SaaS business in China, says VC principal Joshua Wu, but finding the right sales channels might be a challenge.
Search results
Posted inViews
Pinduoduo growth story needs a new chapter
Pinduoduo has a revenue problem—the marketing services it relies on to make money simply don’t sell very well. It’s time for a change of strategy.
Posted inHeavy Hitters
Nio, Xpeng, Li Auto: your cheat sheet to China’s listed Tesla rivals
There are now three Chinese premium EV makers listed in US stock markets: Nio, Li Auto, and Xpeng. Let’s get to know them.
Posted inViews
Bytedance is taking over the attention economy
Bytedance is set to shove Baidu aside as the B in BATs, and is taking a bite out of Tencent’s ad revenue. Why? Its ads are just more effective.
Posted inUp and Comers
INSIGHTS | Digital brokers help retail investors go global
Digital brokers see opportunities to help Chinese investors send their money abroad. But ambiguous regulations still create real doubts about the field.
Posted inViews
How a Chinese food delivery app is gambling on nostalgia
Hungry Panda is exporting the Chinese food delivery model to homesick students abroad. But is it just an overseas clone of Eleme?
Posted inThe Numbers
Nio’s revenue beat can’t outshine its struggle for profit
More challenges loom ahead in the pursuit of profit for Nio, as the company fights for market share amid intensifying competition.
Posted inOn the Cusp
INSIGHTS | Who owns ‘internet literature’?
Powered by grassroots fans, Chinese ‘internet literature’ is big business. It does for Chinese film and TV what Marvel comics do for Hollywood.
Posted inHeavy Hitters
Huawei faces uncertain future after US chips deadline
Following a key US deadline Tuesday, Huawei has lost nearly all access to semiconductors linked to US technology. That’s most of its semiconductors.
Posted inViews
CHINA VOICES | The drivers Wuhan is counting on
In translation from our friends at GQ Reports, a dispatch from the blue collar heroes on the front lines of Wuhan’s battle against coronavirus.
